idarubicin has been researched along with Cardiomyopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Arao, Y; Fujimoto, K; Fukaya, K; Furusawa, K; Haga, T; Hiraiwa, H; Kano, N; Kato, H; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Mutsuga, M; Oishi, H; Okumura, T; Sawamura, A; Shimizu, S; Sugiura, Y; Usui, A; Watanabe, N; Yamaguchi, S; Yokoi, T | 1 |
| Ahmed, Z; Batanian, J; Davaro, E; Verma, N | 1 |
| McHowat, J; Sarvazyan, N; Swift, L | 1 |
| Lamm, RD; McCarthy, PM; Sade, RM | 1 |
| Gould, PA; Hengel, CL; Kaye, DM; Russell, PA | 1 |
| Di Marco, A; Lambertenghi-Deliliers, G; Nava, M; Pozzoli, EF; Praga, C; Soligo, DA; Zanon, PL | 1 |
| Green, MD; Muggia, FM | 1 |
| Clagett-Carr, K; Leyland-Jones, B; Russo, M; Sarosy, G; Weiss, RB | 1 |
2 review(s) available for idarubicin and Cardiomyopathies
| Article | Year |
|---|---|
New anthracycline antitumor antibiotics.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin | 1991 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
2 trial(s) available for idarubicin and Cardiomyopathies
| Article | Year |
|---|---|
New anthracycline antitumor antibiotics.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Cardiomyopathies; Carubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Idarubicin; Menogaril; Molecular Structure; Neoplasms; Nogalamycin | 1991 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
6 other study(ies) available for idarubicin and Cardiomyopathies
| Article | Year |
|---|---|
Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Device Removal; Disease Progression; Female; Fibrosis; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myocardium; Time Factors; Ventricular Function, Left | 2020 |
First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia.
Topics: Antibiotics, Antineoplastic; Cardiomyopathies; Fatal Outcome; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute | 2019 |
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cells, Cultured; Daunorubicin; Doxorubicin; Epirubicin; Group VI Phospholipases A2; Heart Ventricles; Idarubicin; Myocytes, Cardiac; Oxidative Stress; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2003 |
Medical ethics collides with public policy: LVAD for a patient with leukemia.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cost-Benefit Analysis; Cytarabine; Health Care Rationing; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Public Policy; United States | 2005 |
Subacute anthracycline cardiotoxicity.
Topics: Adult; Antibiotics, Antineoplastic; Cardiomyopathies; Cytarabine; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Male; Ultrasonography | 2006 |
Selective mitochondrial alterations induced by a single dose of daunorubicin or 4-demethoxydaunorubicin in mouse ventricular myocardium.
Topics: Animals; Cardiomyopathies; Daunorubicin; Endoplasmic Reticulum; Heart; Idarubicin; Male; Mice; Microscopy, Electron; Mitochondria, Heart; Myocardium | 1980 |